Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
株式のランク #27024
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
株価
$0.16240909
最終同期: 2025-03-04
時価総額
$35.68M
変化(1日)
0.27%
変化(1年)
0.00%
CN
取引 Dali Pharmaceuticalco.,Ltd (603963)

カテゴリー

Dali Pharmaceuticalco.,Ltd(603963)の株式分割履歴
Dali Pharmaceuticalco.,Ltd株(シンボル:603963)は合計で3回の株式分割を実施しました。
最新の株式分割はJun 08, 2020に行われました。
Jul 05, 2018より前に購入された603963株は、現在2.197603963株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2020-06-08 13:10 x1.3 x2.197
2019-06-10 13:10 x1.3 x1.69
2018-07-05 13:10 x1.3 x1.3
類似企業または競合他社の株式分割